64Cu-DOTATATE-PET for Lyme Neuroborreliosis
Key facts
- Where
- Copenhagen, DenmarkSee the site
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 90 years old?
Source: NCT06392815, who can take part
Where in Denmark
- Anne-Mette LebechCopenhagen, DenmarkContact: Anne-Mette LebechTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Copenhagen University Hospital, Rigshospitalet
- Trial code
- NCT06392815
- Record updated
- 21 May 2024
- Original description
The aim of the study is to investigate the applicability and performance of 64Cu-DOTATATE PET/CT/MR for diagnosis in patients with Lyme neuroborreliosis (LNB).Read full original descriptionShow less
64Cu-DOTATATE-PET Imaging for Lyme Neuroborreliosis
The aim of the study is to investigate the applicability and performance of 64Cu-DOTATATE PET/CT/MR for diagnosis in patients with Lyme neuroborreliosis (LNB).
In this prospective, observational cohort study with 64Cu-DOTATATE, the investigators wish to include a total of 50 patients clinically suspected of LNB. The investigators will investigate the diagnostic value of 64Cu-DOTATATE-PET comparing clinically suspected and CSF verified LNB patients with clinically suspected patients without CSF verification.
The investigators hypothesize that the information obtained from 64Cu-DOTATATE PET/CT/MRI can improve the diagnostics of LNB as well as that 64Cu-DOTATATE PET/CT/MRI will be able to contribute to the follow-up of patients by adding prognostic information and the risk of persistent symptoms. The application of 64Cu-DOTATATE PET/CT/MRI in the diagnostic work-up of LNB would thus expectedly lead to a more precise diagnosis and risk assessment.
Inclusion: Age ≥ 18 years AND; Clinical suspicion of LNB AND; Must be able to read and understand the patient information and to give informed consent -.
Exclusion: History of allergic reaction attributable to compounds of similar chemical or biologic composition to 64Cu-DOTATATE OR; Pregnancy OR; Breast-feeding OR; Concluded antibiotic treatment OR; Weight more than the maximum weight limit for the PET/CT/MRI bed of the scanner (140 kg) OR; Contraindications to MR (check list) -.